Table 2 Cross-tabulation of risk status, group allocation, and statin prescription before the intervention with arriba TM
Risk group | Statins | Total | Odds ratios | |||
|---|---|---|---|---|---|---|
No | Yes | (95% confidence interval) | ||||
Group 1very high risk | Intervention | n | 3745 | 958 | 4703 | Â |
% | 79.6% | 20.4% | 100.0% | Â | ||
Controls | n | 3534 | 878 | 4412 | 0.97 | |
% | 80.1% | 19.9% | 100.0% | (0.88-1.08) | ||
Group 2 high risk | Intervention | n | 12929 | 1433 | 14362 | Â |
% | 90.0% | 10.0% | 100.0% | Â | ||
Controls | n | 11647 | 1125 | 12772 | 0.87 | |
% | 91.2% | 8.8% | 100.0% | (0.80-0.95) | ||
Group 3 intermediate risk | Intervention | n | 2496 | 132 | 2628 | Â |
% | 95.0% | 5.0% | 100.0% | Â | ||
Controls | n | 2412 | 104 | 2516 | 0.82 | |
% | 95.9% | 4.1% | 100.0% | (0.63-1.06) | ||
Group 4 low risk | Intervention | n | 16717 | 469 | 17186 | Â |
% | 97.3% | 2.7% | 100.0% | Â | ||
Controls | n | 16417 | 391 | 16808 | 0.85 | |
% | 97.7% | 2.3% | 100.0% | (0.74-0.97) | ||